Agonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos.
Agonist triggering combined with oocyte vitrification and ET in a subsequent natural cycle avoids ovarian hyperstimulation syndrome in patients at risk and shows excellent cycle outcome.
IVI-Madrid, Rey Juan Carlos University, Madrid, Spain. juan.garcia.velasco@ivi.es
Juan A
JA
Garcia-Velasco
D001755:Blastocyst; D015925:Cryopreservation; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D004624:Embryo Transfer; D019317:Evidence-Based Medicine; D005260:Female; D005300:Fertility Agents, Female / Q000008:administration & dosage* / Q000009:adverse effects; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists* / Q000378:metabolism; D006801:Humans; D054315:Oocyte Retrieval; D009865:Oocytes; D016471:Ovarian Hyperstimulation Syndrome / Q000139:chemically induced / Q000378:metabolism / Q000517:prevention & control*; D010060:Ovulation / Q000187:drug effects*; D010062:Ovulation Induction / Q000009:adverse effects; D011247:Pregnancy; D018873:Pregnancy Rate; D058989:Vitrification
D005300:Fertility Agents, Female; D007987:Gonadotropin-Releasing Hormone